Medtronic Announces European Launch of World's First Infusion Set with Wear up to Seven Days to Help Reduce Burden for People with Diabetes News provided by Share this article Share this article DUBLIN, April 14, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today introduced in select European countries the Medtronic Extended infusion set — the first and only infusion set that can be worn for up to 7 days. An infusion set is tubing that delivers insulin from the pump to the body and typically requires a set change every few days. The innovative design of the Medtronic Extended Infusion Set leverages advanced materials that help reduce insulin preservative loss and maintains insulin flow and stability. The new tubing connector improves physical and chemical stability of insulin, reliability of infusion site performance, and reduces the risk of infusion set occlusion. The adhesive patch has an adhesive layer that extends wear time and durability for up to 7 days.